Patrick Branigan

2.6k total citations
52 papers, 1.9k citations indexed

About

Patrick Branigan is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Patrick Branigan has authored 52 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 20 papers in Epidemiology and 12 papers in Genetics. Recurrent topics in Patrick Branigan's work include Respiratory viral infections research (10 papers), Psoriasis: Treatment and Pathogenesis (9 papers) and Inflammatory Bowel Disease (9 papers). Patrick Branigan is often cited by papers focused on Respiratory viral infections research (10 papers), Psoriasis: Treatment and Pathogenesis (9 papers) and Inflammatory Bowel Disease (9 papers). Patrick Branigan collaborates with scholars based in United States, United Kingdom and Germany. Patrick Branigan's co-authors include Alan P. Hudson, Hervé C. Gérard, Kirstin Mitchell, H. Ralph Schumacher, Judith A. Whittum‐Hudson, J. T. Abrams, Denah M. Appelt, Brian J. Balin, Kaye Wellings and Kristian Reich and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Infection and Immunity.

In The Last Decade

Patrick Branigan

48 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Branigan United States 23 681 526 374 344 284 52 1.9k
Richard Loh Australia 26 1.0k 1.5× 446 0.8× 100 0.3× 960 2.8× 367 1.3× 72 2.8k
A Miettinen Finland 22 340 0.5× 641 1.2× 474 1.3× 119 0.3× 70 0.2× 64 1.7k
Ann Marie Bongiovanni United States 24 383 0.6× 369 0.7× 291 0.8× 82 0.2× 90 0.3× 86 1.5k
Arjen Nikkels Belgium 30 470 0.7× 1.4k 2.7× 70 0.2× 141 0.4× 898 3.2× 228 2.7k
K Friese Germany 28 560 0.8× 490 0.9× 129 0.3× 63 0.2× 71 0.3× 230 2.4k
Laurent Bélec France 19 247 0.4× 724 1.4× 275 0.7× 134 0.4× 40 0.1× 54 1.9k
Maria Luisa Villa Italy 28 1.8k 2.7× 700 1.3× 177 0.5× 112 0.3× 68 0.2× 73 3.2k
Christina H. Park United States 10 360 0.5× 173 0.3× 492 1.3× 147 0.4× 69 0.2× 16 2.4k
N Cappello Italy 21 362 0.5× 632 1.2× 89 0.2× 77 0.2× 370 1.3× 56 2.0k
M. de Groot Netherlands 5 1.8k 2.6× 402 0.8× 68 0.2× 112 0.3× 104 0.4× 5 2.7k

Countries citing papers authored by Patrick Branigan

Since Specialization
Citations

This map shows the geographic impact of Patrick Branigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Branigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Branigan more than expected).

Fields of papers citing papers by Patrick Branigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Branigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Branigan. The network helps show where Patrick Branigan may publish in the future.

Co-authorship network of co-authors of Patrick Branigan

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Branigan. A scholar is included among the top collaborators of Patrick Branigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Branigan. Patrick Branigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sridhar, Siddharth, Shadi Yarandi, Matthew Germinaro, et al.. (2025). P0061 Guselkumab induction therapy results in molecular resolution of inflammation in moderately to severely active Ulcerative Colitis: results from the Phase 3 QUASAR induction study. Journal of Crohn s and Colitis. 19(Supplement_1). i421–i422.
2.
Blauvelt, Andrew, Richard G. Langley, Patrick Branigan, et al.. (2024). Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy. SHILAP Revista de lepidopterología. 4(5). 100287–100287. 3 indexed citations
3.
Blauvelt, Andrew, Kenneth B. Gordon, Richard G. Langley, et al.. (2024). Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2. Journal of Investigative Dermatology. 144(12). 2816–2819.e2.
4.
Blauvelt, Andrew, Yanqing Chen, Patrick Branigan, et al.. (2024). Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy. SHILAP Revista de lepidopterología. 4(5). 100297–100297. 4 indexed citations
5.
Sridhar, Saranya, Darren Ruane, Daniel Horowitz, et al.. (2024). OP23 Guselkumab induction restores intestinal immune homeostasis and promotes epithelial repair in moderately to severely active Ulcerative Colitis. Journal of Crohn s and Colitis. 18(Supplement_1). i41–i41. 2 indexed citations
6.
Campbell, Kim, Katherine Li, Feifei Yang, et al.. (2023). Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab. ImmunoHorizons. 7(4). 273–285. 7 indexed citations
7.
Rymarczyk, Dawid, Joshua R. Friedman, Tomasz Danel, et al.. (2023). Deep Learning Models Capture Histological Disease Activity in Crohn’s Disease and Ulcerative Colitis with High Fidelity. Journal of Crohn s and Colitis. 18(4). 604–614. 27 indexed citations
8.
Finney, Lydia, Dexter Wiseman, Anthony Rowe, et al.. (2023). Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study. ERJ Open Research. 9(6). 366–2023. 1 indexed citations
9.
10.
Pavlidis, Stelios, Calixte S. Monast, Matthew J. Loza, et al.. (2019). I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. PLoS Computational Biology. 15(4). e1006951–e1006951. 16 indexed citations
11.
Gordon, Kenneth B., April W. Armstrong, Peter Foley, et al.. (2019). Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study. Journal of Investigative Dermatology. 139(12). 2437–2446.e1. 76 indexed citations
12.
Branigan, Patrick, Yanqing Chen, Ketao Ma, et al.. (2017). 300 Guselkumab attenuates disease- and mechanism-related biomarkers in patients with moderate-to-severe plaque psoriasis. Journal of Investigative Dermatology. 137(5). S51–S51. 8 indexed citations
13.
Bonville, Cynthia A., Manika Suryadevara, Patrick Branigan, et al.. (2013). Novel Inflammatory Markers, Clinical Risk Factors and Virus Type Associated With Severe Respiratory Syncytial Virus Infection. The Pediatric Infectious Disease Journal. 32(12). e437–e442. 80 indexed citations
14.
Bonville, Cynthia A., et al.. (2009). Clinical Features, Adenovirus Types, and Local Production of Inflammatory Mediators in Adenovirus Infections. The Pediatric Infectious Disease Journal. 28(5). 376–380. 51 indexed citations
15.
Reed, Jennifer M., Patrick Branigan, & Anil Bamezai. (2008). Interferon Gamma Enhances Clonal Expansion and Survival of CD4 + T Cells. Journal of Interferon & Cytokine Research. 28(10). 611–622. 27 indexed citations
16.
Held, Katherine S., William G. Glass, Ted Petley, et al.. (2008). Generation of a Protective T-Cell Response Following Coronavirus Infection of the Central Nervous System Is Not Dependent on IL-12/23 Signaling. Viral Immunology. 21(2). 173–188. 16 indexed citations
17.
18.
Bonville, Cynthia A., Nicholas J. Bennett, Caroline M. Percopo, et al.. (2007). Diminished inflammatory responses to natural pneumovirus infection among older mice. Virology. 368(1). 182–190. 10 indexed citations
19.
Schumacher, H. Ralph, et al.. (1999). Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis & Rheumatism. 42(9). 1889–1893. 65 indexed citations
20.
Gérard, Hervé C., et al.. (1998). Viability of chlamydia trachomatis in fallopian tubes of patients with ectopic pregnancy. Fertility and Sterility. 70(5). 945–948. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Loh Breakdown of academic impact, for papers by A Miettinen Breakdown of academic impact, for papers by Ann Marie Bongiovanni Breakdown of academic impact, for papers by Arjen Nikkels Breakdown of academic impact, for papers by K Friese Breakdown of academic impact, for papers by Laurent Bélec Breakdown of academic impact, for papers by Maria Luisa Villa Breakdown of academic impact, for papers by Christina H. Park Breakdown of academic impact, for papers by N Cappello Breakdown of academic impact, for papers by M. de Groot
Rankless by CCL
2026